MedTrace Logo

Safety of Different Forms of Creatine

NCT03039829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2017-02-01

No results posted yet for this study

Summary

This study will aim to determine whether ingesting creatine nitrate (CrN) at higher doses will differentially affect hemodynamic variables compared to a placebo.

Conditions

  • Nutritional Supplements

Interventions

DIETARY_SUPPLEMENT

Creatine nitrate, low dose

Creatine nitrate at 3.0 grams (2.0 grams creatine, 1.0 gram nitrate, 3.0 grams dextrose)

DIETARY_SUPPLEMENT

Creatine nitrate, high dose

Creatine nitrate at 6.0 grams (4.0 grams creatine, 2.0 grams nitrate)

DIETARY_SUPPLEMENT

Placebo

Placebo at 6.0 grams (6.0 grams dextrose)

Sponsors & Collaborators

Principal Investigators

  • Richard B Kreider, PhD · Texas A&M University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039829 on ClinicalTrials.gov